Search

everythinglearnresearchcommunity

for

Search:↓

An imbalance between certain immune cells is linked to a chronic skin condition and may be influenced by obesity, smoking, and autoimmune issues.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

People with alopecia areata have more Th17 cells and fewer Treg cells, which may be key to the condition's development.

The hamster polyomavirus middle T antigen is linked to tumors in hamsters and associates with a specific tyrosine kinase.

Certain immune cells contribute to skin autoimmune diseases, and some treatments can reverse hair loss in these conditions.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

Special immune cells called Regulatory T cells help control skin inflammation and repair in various skin diseases.

Malt1 protease is essential for regulatory T cell function and could be targeted to boost antitumor immunity.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

COVID-19 vaccination may trigger recurrence of cutaneous T-cell lymphoma in some patients.

Frontal fibrosing alopecia is linked to increased immune system activity and reduced stem cells, suggesting early treatment targeting this pathway might prevent hair follicle damage.

Regulatory T cells are essential for normal and improved wound healing in mice.

VDC-1101 shows potential as a treatment for canine cutaneous T-cell lymphoma.

Human dermal γδT-cells respond to stress in hair follicles, contributing to hair loss.

Regulatory T cells help prevent autoimmunity and have potential for treating autoimmune diseases.

ISCK03 stops melanin production in human melanoma cells and lightens skin color in mice and guinea pigs.

A new mouse model effectively mimics vitiligo for research and drug testing.

Treg dysfunction is linked to various autoimmune skin diseases, and understanding Treg properties is key for new treatments.

Diffuse alopecia areata involves more inflammation and higher allergy-related antibodies than patchy types.

γδ T cells adapt uniquely to different tissues in mice.

Targeting Vδ1+T-cells may help treat alopecia areata.

Regulatory T cells protect hair follicle stem cells by maintaining immune privilege in the skin.

People with alopecia areata have fewer regulatory T-cells than those with other skin conditions.

T-cells in alopecia areata scalp show abnormal regulation, leading to less inflammation.

CD3+ T-cell presence is a reliable marker to tell apart alopecia areata from pattern hair loss.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

Overexpressing Tβ4 in cashmere goats improves hair fiber traits and increases cashmere yield.

Overexpressing Tβ4 in goats' hair follicles increases cashmere production and hair follicle growth.

SOCS3 treatment can prevent hair loss by stopping harmful immune responses.

Some patients with a type of skin lymphoma can experience a rare, non-scarring hair loss that looks like another hair loss condition but has distinct features.